Everyone knows someone with cancer or that has died from cancer. It's
time for some new awareness...knowledge and real honesty about cancer,
treatment and recovery, not death from cancer and/or its treatment.
Please pass this blog on. Thank You & God Bless.
World's #1 Publisher of Information About Alternative Cancer Treatments
Your Solution For Disease FREE Health.
Continued From Last Post
Treatment was performed on 50 patients during the last three years
at Life Sciences Universal Medical Clinics in Rockville MD and in
Washington D.C. All patients were terminal subjects with generalized
metastatic disease. Forty-seven of the 50 patients studies had received
maximal modalities of treatment, i.e., surgery, radiation, and various
chemotherapy, before metabolic Cs-treatment was initiated. Three
patients were comatose and 14 of the patients were considered terminal
due to previous treatments outcome and cancer complications. The type of
cancer of the patients studied and their number is detailed in table 1.
The Cs-treatment was given in conjunction of other supportive
compounds under diet control in addition to the utilization of specific
compounds to produce adequate circulation and oxygenation. According to
individual cases CsCl was given at daily dosages of 6 to 9 grams in 3
equally divided doses, with vitamin A-emulsion (100,000 to 300,000 U),
vitamin C (4 to 30 grams), zinc (80 to 100 mg) selenium (600 to 1,200
mcg) and amygdalin (1,500 mg) in addition to other supplementations
according to the specific needs of the patient. The diet consisted
mainly of whole grains, vegetables, linolenic acid rich oils (linseed,
walnut, soy, wheat germ) and other supplemental food. To increase
efficiency of the treatment and improve the circulation and oxygenation,
the patients received the chelating agent EDTA, dimethylsulfoxide (DMSO)
and also a combination of vitamins, K and Mg salts.
Table 1 summarizes the results of the Cs-treatment of 50 cancer
patients studied over 3 years. They had generalized metastatic disease,
except for 3 patients. Initial death occurrences for the initial 2 week
treatment was in the same order and magnitude of these recorded for the
12 month period. The percent of survival of breast, colon, prostate,
pancreas, and lung cancer accounted to approximately, 50% recovery which
was higher than that noted for liver cancer and the lymphoma patients
treated. An overall 50% recovery from cancer by the Cs-therapy was
determined in the 50 patients treated. Data from the autopsy made
indicated the absence of tumors in patient dying within 14 days of the
Cs-treatment. One of the most striking effects of the treatment was the
disappearance of pain in all patients within 1 to 3 days after
initiation of the Cs-therapy.
These studies were performed under my direction, initiated in April,
1981. Twenty-eight patients were initially treated with CsCl between
April, 1981 to October, 1982. They were subjected to various cancer
therapies, e.g., surgery, radiation, and chemotherapy, and were
considered terminal cases with metastatic disease except for 3 patients
who were not previously treated. Three patients were comatose at the
time of the Cs treatment. Thirteen patients died within less than 2
weeks of treatment. Each patient showed a reduction in tumor mass by the
Cs-treatment. Of the breast cancer patients, the most impressive effect
was seen in a female patient who was comatose at the beginning of the
Cs-treatment and was considered a terminal case. The Cs-therapy, with
other ingredients used, was immediately instituted by nasogastric route
because there was no cooperation from the patient. The daily CsCl dose
given amounted to 30 grams, 10 grams given 3 times daily. The patient
was able to leave after 5 days of treatment. However the patient's fall
on the floor resulted in complications, i.e., fracture of the neck, and
death. The autopsy revealed that the cancer metastasis had essentially
eaten away her hip bone causing this tragic accident. The autopsy
performed also showed the presence of very little cancer tissue.
The next most frequent cancer treated was of unknown primary.
Treatment of 8 cases showed a death rate of 2 within 14 days of treatment
and an additional 2 deaths within 12 months while 4 of the patients are
still living. In one case, an autopsy was made in a patient after one
week of Cs-treatment and showed a complete disappearance of the cancer.
There were 7 cases of colon cancer patients who were treated with CsCl.
Two of these patients died within 14 days, one of the patients had
previous massive chemotherapy, and little time was available to restore
her metabolic condition. The previous existing infiltration of the
abdominal wall disappeared. However, no consent was given for an
In one lymphoma case the patient displayed an unusually large
abdomen which was hard and he weighed approximately 250 pounds. The
massively enlarged abdomen began to decline in volume, i.e., a loss of
approximately 120 pounds of body weight was noted after 3 months of the
Cs- therapy. The spleen which was originally maximally enlarged and
reaching into the pelvis was reduced to almost normal size. The liver
position was down to about the level of the umbilicus and was also
reduced to normal size in 3 months. The patient is still living after 3
years after his discharge. Unfortunately, there is no follow-p on this
patient and he is being maintained on chemotherapy.
God Bless Everyone & God Bless The United States of America.
42 S. Sherwood Dr.
Belton, Tx. 76513
Income for the 98% that fail in Their Internet Business.
Disclaimer...What you read on this site is opinion only. I am not
a doctor or any specialist in anything pertaining to this site. I'm
only a cancer survivor for over 5 years due to the alternative approach.
I did NOT follow the medical approach...I followed the alternative
approach to curing cancer. Now you know why I have a strong opinion.